Department of Psychiatry, Faculty of health and medical sciences, Mettu University, Mettu, Ethiopia.
Department of Psychiatry, Institute of health, Jimma University, Jimma, Ethiopia.
Health Qual Life Outcomes. 2020 Mar 30;18(1):82. doi: 10.1186/s12955-020-01340-0.
Schizophrenia was ranked as one of the top ten illnesses contributing to the global burden of disease. But little is known about the quality of life among people with schizophrenia, in particular in low-income countries. This study was aimed to examine the association of quality of life with current substance use, medication non-adherence and clinical factors of people with schizophrenia at Jimma University Medical Center, psychiatry clinic, Southwest Ethiopia.
Institution based cross-sectional study design was employed. Study participants were recruited using a systematic random sampling method and a sample fraction of two was used after the first person was identified by the lottery method. we used the World Health Organization Quality of Life Scale-Brief version (WHOQoL-BREF) and 4-item Morisky Medication Adherence Scale (MMAS-4) to assess the quality of life and medication non-adherence respectively. Data about current substance use was assessed by yes/no questions. Descriptive statistics, such as frequency, mean and standard deviations were computed to describe the characteristics of the study population. Data entry was done using EpiData version 3.1 then exported to SPSS statistics version 25 for analysis and analyzed using multiple linear regression. The assumption for linear regression analysis including the presence of a linear relationship between the outcome and predictor variable, the test of normality, collinearity statistics, auto-correlation and homoscedasticity were checked. Un-standardized Beta (β) coefficients with 95% confidence interval (CI) and P-value < 0.05 were computed to assess the level of association and statistical significance in the final multiple linear regression analysis.
In this study 31.65% of participants were medication non-adherent and total mean scores of quality of life showed a lower level of satisfaction in social relationship domain (10.14 ± 3.12). Our study showed 152(43.3%), 248(70.7%) and 97(27.6%) of respondents had used tobacco, Khat and alcohol atleast once during the past 3 months respectively. Final adjusted multiple regression model showed medication non-adherence has significant negative association with physical domain (beta = - 4.42, p < 0.001), psychological (beta = - 4.49, p < 0.001), social relationships (beta = - 2.29, p < 0.001) and environmental domains (beta = - 4.95, p < 0.001). Treatment duration has significant negative association with psychological domain (beta = - 0.17, p < 0.04), social relationship (beta = - 0.14, p < 0.005), environmental domain (beta = - 0.24, p < 0.02) and overall quality of life (beta = - 0.67, p < 0.02). Having comorbid physical illness has significant negative association with physical domain (beta = - 2.74, p < 0.001), psychological (beta = - 2.13, p < 0.004), social relationships (beta = - 1.25, p < 0.007), environmental domain (beta = - 3.39, p < 0.001) and overall quality of life (beta = - 9.9, p < 0.001). Current tobacco use has significant negative association with physical domain (beta = - 1.16, p < 0.004), psychological (beta = - 1.23, p < 0.001), social relationships (beta = - 0.88, p < 0.001), environmental domains (beta = - 1.98, p < 0.001) and overall quality of life (beta = - 5.73, p < 0.001). Also, current chewing khat has significant negative association with physical domain (beta = - 1.15, p < 0.003), psychological (beta = - 1.58, p < 0.001), environmental domains (beta = - 2.63, p < 0.001) and overall quality of life (beta = - 6.22, p < 0.001).
The social relationship domain of quality of life has the lowest mean score. Medication non-adherence, treatment duration, having a comorbid physical illness, current tobacco use and current chewing khat were found to have a statistically significant association with the overall quality of life. Therefore, treatments aimed to improve social deficits, medication non-adherence, comorbid physical illness and decrease substance abuse is imperative.
精神分裂症是导致全球疾病负担的十大疾病之一。但是,对于精神分裂症患者的生活质量,特别是在低收入国家,人们知之甚少。本研究旨在探讨生活质量与当前物质使用、药物依从性和临床因素的关系,研究对象为埃塞俄比亚西南部季马大学医疗中心精神病诊所的精神分裂症患者。
采用基于机构的横断面研究设计。使用系统随机抽样法招募研究参与者,并在确定第一人后使用样本分数为二分之一的抽签法抽取样本。我们使用世界卫生组织生活质量量表-简短版(WHOQoL-BREF)和 4 项 Morisky 药物依从性量表(MMAS-4)分别评估生活质量和药物不依从性。当前物质使用情况通过是/否问题进行评估。使用频率、平均值和标准差等描述性统计数据来描述研究人群的特征。数据输入使用 EpiData 版本 3.1,然后导出到 SPSS 统计版本 25 进行分析,并使用多元线性回归进行分析。线性回归分析的假设包括:结果和预测变量之间存在线性关系、正态性检验、共线性统计、自相关和同方差性。在最终的多元线性回归分析中,计算未标准化的β系数(β)及其 95%置信区间(CI)和 P 值<0.05,以评估关联和统计显著性。
在这项研究中,31.65%的参与者药物依从性差,生活质量总平均分显示社会关系领域的满意度较低(10.14±3.12)。我们的研究显示,152(43.3%)、248(70.7%)和 97(27.6%)的受访者在过去 3 个月内至少使用过烟草、阿拉伯茶和酒精。最终调整后的多元回归模型显示,药物不依从性与身体(β=-4.42,p<0.001)、心理(β=-4.49,p<0.001)、社会关系(β=-2.29,p<0.001)和环境领域(β=-4.95,p<0.001)显著负相关。治疗持续时间与心理(β=-0.17,p<0.04)、社会关系(β=-0.14,p<0.005)、环境领域(β=-0.24,p<0.02)和整体生活质量(β=-0.67,p<0.02)显著负相关。合并躯体疾病与身体(β=-2.74,p<0.001)、心理(β=-2.13,p<0.004)、社会关系(β=-1.25,p<0.007)、环境领域(β=-3.39,p<0.001)和整体生活质量(β=-9.9,p<0.001)显著负相关。当前吸烟与身体(β=-1.16,p<0.004)、心理(β=-1.23,p<0.001)、社会关系(β=-0.88,p<0.001)、环境领域(β=-1.98,p<0.001)和整体生活质量(β=-5.73,p<0.001)显著负相关。目前咀嚼阿拉伯茶也与身体(β=-1.15,p<0.003)、心理(β=-1.58,p<0.001)、环境领域(β=-2.63,p<0.001)和整体生活质量(β=-6.22,p<0.001)显著负相关。
生活质量的社会关系领域的平均分最低。药物不依从性、治疗持续时间、合并躯体疾病、当前吸烟和咀嚼阿拉伯茶与整体生活质量有统计学显著关联。因此,改善社会缺陷、药物不依从性、合并躯体疾病和减少物质滥用的治疗方法至关重要。